Ripertamab
Modify Date: 2024-04-06 10:18:52
Ripertamab structure
|
Common Name | Ripertamab | ||
|---|---|---|---|---|
| CAS Number | 2249927-04-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RipertamabRipertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL)[1]. |
| Name | Ripertamab |
|---|
| Description | Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Kaplon H, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14(1):2014296. |
| No Any Chemical & Physical Properties |